Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solumedrol Pulse Therapy in Refractory Rheumatoid Arthritis
NCT06456489Phase 3Recruiting
- Sponsor
- Sohag University
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in rheumatoid arthritis (RA), sponsored by Sohag University. Started May 2024; status: recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06456489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06456489.